Review on porous materials for the thermal stabilization of proteins
NA Montoya, RE Roth, EK Funk, P Gao… - Microporous and …, 2022 - Elsevier
Proteins, the key components of vaccines, enzymes and many types of therapeutics, are
sensitive to denaturing and loss of structure when exposed to high temperatures. One way to …
sensitive to denaturing and loss of structure when exposed to high temperatures. One way to …
Investigating BioCaRGOS, a Sol–Gel Matrix for the Stability of Heme Proteins under Enzymatic Degradation and Low pH
There have been significant advances in the development of vaccines for the prevention of
various infectious diseases in the last few decades. These vaccines are mainly composed of …
various infectious diseases in the last few decades. These vaccines are mainly composed of …
Long term storage of miRNA at room and elevated temperatures in a silica sol–gel matrix
R Chauhan, TS Kalbfleisch, CS Potnis, M Bansal… - RSC …, 2021 - pubs.rsc.org
Storage of biospecimens in their near native environment at room temperature can have a
transformative global impact, however, this remains an arduous challenge to date due to the …
transformative global impact, however, this remains an arduous challenge to date due to the …
Protein Thermal Stabilization and Delivery via Adsorption onto Porous Silicas
NM Oyuela - 2022 - search.proquest.com
The cold chain is a problem that affects the whole pharmaceutical industry: in 2019, 45% of
new FDA approved drugs required refrigeration or freezing. It is estimated that biopharma …
new FDA approved drugs required refrigeration or freezing. It is estimated that biopharma …